25.84 USD
+0.22 (+0.86%)
25.84 USD
0 (0%)
We assign a fundamental rating of 7 out of 10 to PGNY. PGNY was compared to 101 industry peers in the Health Care Providers & Services industry. PGNY scores excellent points on both the profitability and health parts. This is a solid base for a good stock. PGNY is growing strongly while it is still valued neutral. This is a good combination! This makes PGNY very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
PGNY had positive earnings in the past year.
PGNY had a positive operating cash flow in the past year.
PGNY had positive earnings in each of the past 5 years.
PGNY had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.11%, PGNY belongs to the top of the industry, outperforming 88.12% of the companies in the same industry.
Looking at the Return On Equity, with a value of 10.10%, PGNY is in the better half of the industry, outperforming 71.29% of the companies in the same industry.
PGNY's Return On Invested Capital of 11.24% is amongst the best of the industry. PGNY outperforms 83.17% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PGNY is in line with the industry average of 9.58%.
The 3 year average ROIC (8.25%) for PGNY is below the current ROIC(11.24%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| ROIC | 11.24% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
1.3 Margins
Looking at the Profit Margin, with a value of 4.46%, PGNY is in the better half of the industry, outperforming 77.23% of the companies in the same industry.
In the last couple of years the Profit Margin of PGNY has declined.
The Operating Margin of PGNY (6.77%) is better than 69.31% of its industry peers.
PGNY's Operating Margin has improved in the last couple of years.
PGNY has a Gross Margin (22.94%) which is comparable to the rest of the industry.
PGNY's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.77% | ||
| PM (TTM) | 4.46% | ||
| GM | 22.94% |
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PGNY is creating some value.
The number of shares outstanding for PGNY has been reduced compared to 1 year ago.
Compared to 5 years ago, PGNY has more shares outstanding
PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
PGNY has an Altman-Z score of 8.54. This indicates that PGNY is financially healthy and has little risk of bankruptcy at the moment.
PGNY's Altman-Z score of 8.54 is amongst the best of the industry. PGNY outperforms 94.06% of its industry peers.
There is no outstanding debt for PGNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.54 |
ROIC/WACC1.26
WACC8.93%
2.3 Liquidity
A Current Ratio of 2.96 indicates that PGNY has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.96, PGNY belongs to the top of the industry, outperforming 84.16% of the companies in the same industry.
PGNY has a Quick Ratio of 2.96. This indicates that PGNY is financially healthy and has no problem in meeting its short term obligations.
PGNY's Quick ratio of 2.96 is amongst the best of the industry. PGNY outperforms 84.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.96 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 8.62% over the past year.
The Earnings Per Share has been decreasing by -4.77% on average over the past years.
Looking at the last year, PGNY shows a quite strong growth in Revenue. The Revenue has grown by 11.41% in the last year.
The Revenue has been growing by 38.42% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)8.62%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%36.36%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.32%
3.2 Future
Based on estimates for the next years, PGNY will show a very strong growth in Earnings Per Share. The EPS will grow by 32.94% on average per year.
The Revenue is expected to grow by 8.83% on average over the next years. This is quite good.
EPS Next Y17.75%
EPS Next 2Y38.5%
EPS Next 3Y32.43%
EPS Next 5Y32.94%
Revenue Next Year11.28%
Revenue Next 2Y10.4%
Revenue Next 3Y10.6%
Revenue Next 5Y8.83%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 41.02, which means the current valuation is very expensive for PGNY.
PGNY's Price/Earnings is on the same level as the industry average.
PGNY's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.77.
PGNY is valuated rather expensively with a Price/Forward Earnings ratio of 23.63.
PGNY's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.35, PGNY is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.02 | ||
| Fwd PE | 23.63 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as PGNY.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PGNY indicates a rather cheap valuation: PGNY is cheaper than 82.18% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.51 | ||
| EV/EBITDA | 18.3 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PGNY does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of PGNY may justify a higher PE ratio.
PGNY's earnings are expected to grow with 32.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.31
PEG (5Y)N/A
EPS Next 2Y38.5%
EPS Next 3Y32.43%
5. Dividend
5.1 Amount
No dividends for PGNY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
25.84
+0.22 (+0.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.97%
Inst Owner Change7.39%
Ins Owners1.49%
Ins Owner Change0.8%
Market Cap2.23B
Revenue(TTM)1.27B
Net Income(TTM)56.57M
Analysts81.25
Price Target29.68 (14.86%)
Short Float %7.13%
Short Ratio3.53
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.43%
Min EPS beat(2)14.22%
Max EPS beat(2)14.63%
EPS beat(4)3
Avg EPS beat(4)8.02%
Min EPS beat(4)-11.77%
Max EPS beat(4)15%
EPS beat(8)5
Avg EPS beat(8)7.07%
EPS beat(12)9
Avg EPS beat(12)35.08%
EPS beat(16)13
Avg EPS beat(16)94.29%
Revenue beat(2)2
Avg Revenue beat(2)2.31%
Min Revenue beat(2)1.96%
Max Revenue beat(2)2.66%
Revenue beat(4)4
Avg Revenue beat(4)3.39%
Min Revenue beat(4)1.96%
Max Revenue beat(4)5.74%
Revenue beat(8)4
Avg Revenue beat(8)-0.43%
Revenue beat(12)7
Avg Revenue beat(12)0.39%
Revenue beat(16)9
Avg Revenue beat(16)-0.09%
PT rev (1m)1.12%
PT rev (3m)1.34%
EPS NQ rev (1m)0.39%
EPS NQ rev (3m)5.45%
EPS NY rev (1m)6.34%
EPS NY rev (3m)6.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.13%
Revenue NY rev (1m)1.4%
Revenue NY rev (3m)1.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.02 | ||
| Fwd PE | 23.63 | ||
| P/S | 1.76 | ||
| P/FCF | 11.51 | ||
| P/OCF | 10.7 | ||
| P/B | 3.98 | ||
| P/tB | 4.17 | ||
| EV/EBITDA | 18.3 |
EPS(TTM)0.63
EY2.44%
EPS(NY)1.09
Fwd EY4.23%
FCF(TTM)2.24
FCFY8.68%
OCF(TTM)2.41
OCFY9.34%
SpS14.72
BVpS6.5
TBVpS6.19
PEG (NY)2.31
PEG (5Y)N/A
Graham Number9.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| ROCE | 14.68% | ||
| ROIC | 11.24% | ||
| ROICexc | 27.43% | ||
| ROICexgc | 30.82% | ||
| OM | 6.77% | ||
| PM (TTM) | 4.46% | ||
| GM | 22.94% | ||
| FCFM | 15.25% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
ROICexc(3y)19.18%
ROICexc(5y)17.15%
ROICexgc(3y)20.6%
ROICexgc(5y)18.86%
ROCE(3y)10.79%
ROCE(5y)10.01%
ROICexgc growth 3Y11.16%
ROICexgc growth 5Y-10.91%
ROICexc growth 3Y11.54%
ROICexc growth 5Y-2.19%
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
F-Score7
Asset Turnover1.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 330.21% | ||
| Cap/Sales | 1.16% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 230.54% | ||
| Profit Quality | 342.01% | ||
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.96 | ||
| Altman-Z | 8.54 |
F-Score7
WACC8.93%
ROIC/WACC1.26
Cap/Depr(3y)177.5%
Cap/Depr(5y)150.16%
Cap/Sales(3y)0.4%
Cap/Sales(5y)0.39%
Profit Quality(3y)290.66%
Profit Quality(5y)196.79%
High Growth Momentum
Growth
EPS 1Y (TTM)8.62%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%36.36%
EPS Next Y17.75%
EPS Next 2Y38.5%
EPS Next 3Y32.43%
EPS Next 5Y32.94%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.32%
Revenue Next Year11.28%
Revenue Next 2Y10.4%
Revenue Next 3Y10.6%
Revenue Next 5Y8.83%
EBIT growth 1Y31.12%
EBIT growth 3Y27.82%
EBIT growth 5Y41.01%
EBIT Next Year39.66%
EBIT Next 3Y20.34%
EBIT Next 5Y15.66%
FCF growth 1Y-2.78%
FCF growth 3Y93.67%
FCF growth 5YN/A
OCF growth 1Y2.69%
OCF growth 3Y90.18%
OCF growth 5YN/A
PROGYNY INC / PGNY FAQ
What is the fundamental rating for PGNY stock?
ChartMill assigns a fundamental rating of 7 / 10 to PGNY.
What is the valuation status for PGNY stock?
ChartMill assigns a valuation rating of 4 / 10 to PROGYNY INC (PGNY). This can be considered as Fairly Valued.
How profitable is PROGYNY INC (PGNY) stock?
PROGYNY INC (PGNY) has a profitability rating of 7 / 10.
What are the PE and PB ratios of PROGYNY INC (PGNY) stock?
The Price/Earnings (PE) ratio for PROGYNY INC (PGNY) is 41.02 and the Price/Book (PB) ratio is 3.98.
Can you provide the expected EPS growth for PGNY stock?
The Earnings per Share (EPS) of PROGYNY INC (PGNY) is expected to grow by 17.75% in the next year.